Not Yet RecruitingNot Applicable

Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block

Egypt50 participantsStarted 2025-01

Plain-language summary

The aim of this study to determine the optimal dose of dexmedetomidine as an adjuvant to bupivacaine in U.S guided TAP block for preemptive analgesia In patients undergoing lower abdominal cancer surgeries.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age from 18 to 65 years old * lower abdominal cancer surgery Exclusion Criteria: * patient refusal * the local anesthetic allergy * coagulopathy * local infection at the procedure site * psychic patients * patient on chronic opioid use

What they're measuring

Total morphine consumption during the first 24 hours postoperatively

Timeframe: First 24 hours postoperative

Trial details

NCT IDNCT06624319

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01

Contact for this trial

Kerolos S Tawfeek, Resident

+2001551990411 Kerolossalama7@gmail.com

View on ClinicalTrials.gov More Post Operative Pain trials